|Shanghai Teresa Healthcare Sci-Tech Co., Ltd., a privately owned hi-tech enterprise enrolled in Shanghai Caohejing Hi-tech Park, was founded in 2004 by a team of postgraduates with PhD, MD, and MBA from the celebrated universities worldwide, now integrated with marketing and manufacture. The team members have strong capability in product R&D, sales and marketing as well as rich experiences in business administration. Currently engaged in the field of biophysics and biomedical therapy, Teresa Healthcare has been addressing to the development of novel core technology of electroporation (EPT), such as drug-appliance combination product and medical rehabilitation device. To insure its leading competition and sustainability, Teresa Healthcare has a high-level academic collaboration worldwide and retains a board of scientific advisors in biotechnology, computer, biomedical and pharmaceutical science from Shanghai Jiaotong University, Jilin University as well as the Newcastle University, UK .|
Up to the present, Teresa Healthcare has obtained Enterprise License for Medical Device Manufacture and Registered Product Certificate issued by the Shanghai Food and Drug Administration. Teresa Healthcare has also obtained one certificate of Shanghai Transformed Hi-tech Product, as well as five certificates of Registered Software Copyrights and seven Invention Patents issued by the Chinese National Bureau of Intellectual Asset. In October 2005, Teresa has launched the rehabilitation device to protect muscle from atrophy. In Sept. 2006, TERESA-EPT-I Drug Delivery Device (DDD) was approved for special clinical trial by SFDA, which was initiated in Dec 2007.